SP

Saravanan Palanichamy

Active Director Director DIN 10923521
DIN 10923521 First appointment Jan 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Saravanan Palanichamy

Data last updated:

Saravanan Palanichamy is a Director at Aspire Biomedical Private Limited (since 2025). Aspire Biomedical Private Limited reported revenue of ₹2.3 Lakh (FY 2024).

DIN 10923521
Primary Designation Director
First Appointment 27 Jan 2025
Oldest Company Age 2 yrs
Largest company Aspire Biomedical Private Limited · ₹2.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aspire Biomedical Private Limited U46596TN2023PTC165394
Director27 Jan 20252023₹2.3 Lakh (FY 2024)Active

Board colleagues of Saravanan Palanichamy

Directorship timeline

Open interactive timeline →
Aspire Biomedical Private Limited
Premium access

Shareholding and investment profile for Saravanan Palanichamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saravanan Palanichamy

Saravanan Palanichamy currently holds 1 directorship: Aspire Biomedical Private Limited (Director, since 27 Jan 2025, revenue ₹2.3 Lakh (FY 2024)).

Saravanan Palanichamy was first appointed on 27 Jan 2025 as Director at Aspire Biomedical Private Limited.

The current boards of Saravanan Palanichamy's companies include Krishnamoorthi Monisha (Aspire Biomedical Private Limited), Subramani Uthayakumar (Aspire Biomedical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available